Upcoming Events for Media
- September 22 - 23 | Annual Congress on Hematologic Malignancies Features Expert Perspectives on Latest Developments in Caring for Persons with Blood Cancers, Including CAR T-Cell Therapy-Related Toxicities, BTKi Inhibitors, Bispecific T-Cell Engagers, Graft-Versus-Host Disease, and More. Learn more and register for a complimentary press pass.
What's New
- Recommendations for Addressing Health-Related Social Needs in Cancer Care Introduced at NCCN Policy Summit. Learn more.
- Most Non-English Speakers in the U.S. Are Turned Away Before Their First Cancer Visit According to New Research in JNCCN. Learn more.
Stay up-to-date on NCCN by subscribing to our eBulletin newsletter here.
Contact
Rachel Darwin, Senior Manager, Public Relations
darwin@nccn.org, 267-622-6624
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted
to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide
transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated
clinical practice guidelines available in any area of medicine.
Multi-disciplinary subject matter experts from across the NCCN Guidelines® panels are available for interviews.
NCCN neither reviews nor approves press releases announcing the inclusion of tests, agents, and/or therapies listed within the NCCN Guidelines. For any additional commercial use of NCCN Content in promotional and educational materials, NCCN requires a
license and review of content (visit
Licensing and Permissions or email
PermissionRequest@nccn.org).